HLN (Haleon) Retained Earnings : $35,020 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Haleon's retained earnings for the quarter that ended in Jun. 2024 was $35,020 Mil.

Haleon's quarterly retained earnings declined from Dec. 2023 ($34,777 Mil) to Mar. 2024 ($0 Mil) but then increased from Mar. 2024 ($0 Mil) to Jun. 2024 ($35,020 Mil).

Haleon's annual retained earnings declined from Dec. 2021 ($49,918 Mil) to Dec. 2022 ($32,558 Mil) but then increased from Dec. 2022 ($32,558 Mil) to Dec. 2023 ($34,777 Mil).

Haleon Retained Earnings Historical Data

The historical data trend for Haleon's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Retained Earnings Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Retained Earnings

6,692.01

50,756.72

49,917.55

32,557.86

34,777.22

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Retained Earnings	Get a 7-Day Free Trial										34,397.73	-	34,777.22	-	35,020.36

Haleon Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Haleon (NYSE:HLN) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Haleon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN1:Mexico HLNl:UK HLN:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.